IM 1 Flashcards
What are the 2 types of autoimmune hemolytic anemia?
- Warm aggultinin AIHA
2. Cold agglutinin AIHA
Compare the etiologies of warm vs. cold agglutinin AIHA.
Warm - drugs (eg, penicillin), viral infections, AI (eg, SLE), immunodeficiency states, lymphoproliferative diseases (eg, CLL)
Cold - infections (eg, M. pneumoniae, mononucleosis), lymphoproliferative diseases
Compare the clinical presentation of warm vs. cold agglutinin AIHA.
Warm - asymptomatic to life-threatening anemia
Cold - symptoms of anemia, livedo reticularis and acral cyanosis with cold exposure that disappears with warming
Compare the Coombs’ test results in warm vs. cold agglutinin AIHA.
Warm - Direct Coombs’ positive with anti-IgG, anti-C3, or both
Cold - Direct Coombs’ positive with anti-C3 or anti-IgM, but usually NOT IgG
Treatment of warm agglutinin AIHA?
High dose corticosteroids
Splenectomy for refractory disease
Treatment of cold agglutinin AIHA?
Avoidance of cold temperatures
Rituximab +/- fludarabine
Compare the complications of warm vs. cold agglutinin AIHA.
Warm - VTE, lymphoproliferative disorders
Cold - ischemia and peripheral gangrene, lymphoproliferative disorders
Presentation of warm AIHA?
Normocytic anemia
Evidence of hemolysis (jaundice, elevated indirect bilirubin, increased serum LDH, decreased serum haptoglobin)
Splenomegaly (erythrocyte entrapment)
Reticulocytosis (BM response)
Peripheral smear appearance in warm AIHA?
Spherocytes, microspherocytes, elliptocytes, or increased number of polychromatophilic cells
Diagnose warm AIHA?
Direct antiglobulin (Coombs) test showing autoantibodies (usually anti-IgG) or complement components (eg, anti-C3) bound to the surface of the patient’s RBCs
What is the next step in management of progressive pain in a patient with prostate cancer and bony metastases after androgen ablation (orchiectomy)?
Radiation therapy (focal external beam therapy to sites of mets)
MOA - flutamide?
Non-steroidal anti-androgen via competitive binding to dihydrotestosterone receptors
List the 4 major classes of anticoagulants.
- Heparin
- Vitamin K antagonists
- Direct thrombin inhibitors (argatroban, bivalirudin, dabigatran)
- Factor Xa inhibitors (direct - rivaroxaban and apixaban, indirect - fondaparinux)
MOA - heparins?
Inhibit Xa and IIa (thrombin)
MOA - vitamin K antagonists?
Inhibit synthesis of II, VII, IX, X (vitamin K-dependent clotting factors) and proteins C and S (vitamin-K dependent ANTICOAGULANT proteins)
Why is it important to know that warfarin can lead to decreased protein S?
May lead to an incorrect diagnosis of an inherited protein S deficiency (if possible, discontinue warfarin for 2 weeks prior to evaluating protein S levels)
MOA - aspirin?
Antiplatelet agent, inhibits COX-1 -> inhibits thromboxane A2 synthesis
MOA - clopidogrel?
Antiplatelet agent, prevents platelet activation by blocking adenosine diphosphate receptors on the surface of platelets
MOA - heparin?
Activates antithrombin III, which inactivates factor IIa, IXa, and Xa
MOA - simvastatin?
Lipid-lowering agent, inhibits 3-hydroxy-3-methylglutaryl-coenzyme reductase
List the 4 hereditary thrombophilias.
- Factor V Leiden
- Prothrombin mutation
- Antithrombin deficiency
- Protein C or S deficiency
Typical inheritance pattern of hereditary thrombophilias?
AD with variable penetrance
Presentation of PE that began as a DVT?
SOB, leg swelling, sinus tachycardia, elevated D-dimer
In a young patient with no obvious risk factor for a DVT/PE, what should be considered?
Hypercoagulable disorder
Who should be tested for a hypercoagulable disorder?
Young (<45 years) patients with a first-time unprovoked DVT/PE, patients with recurrent DVT/PE, patients with unusual sites of thrombi (cerebral, mesentery, portal veins, etc.)
Most commonly found hereditary thrombophilia, especially in Caucasians?
Factor V Leiden (FVL)
Pathogenesis of Factor V Leiden?
AD point mutation in the gene for factor V that makes it unable to respond to activated protein C, an innate anticoagulant (activated protein C resistance) -> slowed degradation of procoagulant active factor V -> continued thrombin formation, slowed degradation of active factor VIII
PT and aPTT in Factor V Leiden?
Can be normal, as the major procoagulant effects are due to continued thrombin formation; elements of the coagulation cascade that can be assessed by these tests are less likely to be predominantly affected
Second most common hereditary thrombophilias in Caucasians?
Prothrombin mutation
Pathogenesis - prothrombin mutation?
Increased prothombin levels
Inherited form of antithrombin deficiency is rare - what are 3 acquired causes?
DIC, cirrhosis, nephrotic syndrome
Mechanism of protein C or S deficiency?
Decreased inactivation of factors Va and VIIIa
Etiology of primary hyperparathyroidism?
- Parathyroid adenoma (most common)
- Hyperplasia
- Carcinoma
- Increased risk in MEN 1 and 2A
Symptoms of primary hyperparathyroidism?
Asymptomatic (most common)
Mild, nonspecific symptoms (eg, fatigue, constipation)
Abdominal pain, renal stones, bone pain, neuropsychiatric symptoms
Diagnostic findings of primary hyperparathyroidism?
Hypercalcemia, hypophosphatemia
Elevated or inappropriately normal PTH
Elevated 24-hour urinary calcium excretion
Indications for parathyroidectomy?
Age <50
Symptomatic hypercalcemia
Complications or elevated risk of complications
Complications of primary hyperparathyroidism?
Osteoporosis (T-score
Elevated risk of complications of primary hyperparathyroidism?
Calcium 1+ mg/dL above normal, urinary calcium excretion > 400 mg/day
Pathophysiology of primary hyperparathyroidism?
Increased reabsorption of calcium from the distal tubule
Net urinary clacium excretion is increased due to excess resorption of calcium from bones
Diagnostic features of familial hypocalciuric hypercalcemia?
Hypercalcemia, elevated PTH, low urinary calcium excretion (often <100 mg/24 hours)
What is the purpose of parathyroid imaging in PHPT?
Optimize the surgical approach by potentially determining the affected side and evaluating for the possibility of a minimally invasive surgery